Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.
about
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancerNovel treatments and therapies in development for pancreatic cancer.The pemetrexed/gemcitabine combination in pancreatic cancer.Recent developments in the pharmacological treatment of advanced pancreatic cancer.Developments in metastatic pancreatic cancer: is gemcitabine still the standard?Emerging drugs in pancreatic cancer.Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in BXPC-3 and PANC-1 human pancreatic cancer cells.Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent.A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancerSingle-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions.
P2860
Q33367733-7649C52A-ECC0-43F5-90EC-702DA6EBF796Q33400687-C4CB2D5D-095C-45D6-8314-F5FE47C6D35AQ34660844-324F8CE7-3093-42E9-85A2-D94D25D4384CQ34810763-4792775E-CCDE-4D2B-BEE5-546087F77FC5Q35144004-14891EA7-4888-43E2-A3A3-0E73BCE4607CQ35776091-7BD578D3-3C40-450E-8866-C77277B31126Q35779283-6F0E753B-1AF6-46CE-AB69-7294D7E15A5BQ36230591-02FC4D6D-14DE-45F8-8D78-E60C5E2EB56EQ36429607-0E612059-96EF-4697-AD3D-EBD43C9D7909Q36610441-B4BCF273-08B4-4AB1-A6F4-851BE8E484DBQ46170046-4AF274C5-AA3A-466A-8C35-268D9E01F240
P2860
Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Phase II study of the multitar ...... th advanced pancreatic cancer.
@ast
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
Phase II study of the multitar ...... th advanced pancreatic cancer.
@nl
type
label
Phase II study of the multitar ...... th advanced pancreatic cancer.
@ast
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
Phase II study of the multitar ...... th advanced pancreatic cancer.
@nl
prefLabel
Phase II study of the multitar ...... th advanced pancreatic cancer.
@ast
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
Phase II study of the multitar ...... th advanced pancreatic cancer.
@nl
P2093
P356
P1433
P1476
Phase II study of the multitar ...... th advanced pancreatic cancer.
@en
P2093
D Thornton
E Rowinsky
K D Miller
L N Shulman
P J Loehrer
P304
P356
10.1023/A:1008305205159
P577
2000-01-01T00:00:00Z